City

Jacksonville (1)

Nottingham (1)

Condition

Pancreatic Enzyme Abnormality (2)

Cystic Fibrosis (1)

Digestive System Disease (1)

Distal Intestinal Obstruction Syndrome (1)

Gastrointestinal System Disease (1)

Lung Diseases (1)

Pancreatic Cancer (1)

Pancreatic Disease (1)

Pancreatic Insufficiency (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Massimo Raimondo, M.D. (1)

Nottingham University Hospitals NHS Trust (1)

Collaborator

Digestive Care, Inc. (1)

Royal Brompton & Harefield NHS Foundation Trust (1)

Seattle Children's Hospital (1)

The Leeds Teaching Hospitals NHS Trust (1)

University of Washington (1)

Intervention

no intervention (1)

pancrelipase (1)

placebo oral capsule (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

pancreatic enzyme abnormality

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

CFTR Modulators and Gastrointestinal Complications

Active, not recruiting

Cystic Fibrosis
+6 more

No intervention

Nottingham, United Kingdom

Nottingham University Hospitals NHS Trust

Jul 7, 2022

Pancreatic Insufficiency, Pancreatic Cancer, Pancreatic Enzyme Abnormality Trial in Jacksonville (Pancrelipase, Placebo Oral

Terminated

Has Results

Pancreatic Insufficiency
+2 more

Pancrelipase
Placebo Oral Capsule

Jacksonville, Florida

Mayo Clinic

Feb 22, 2021